Literature DB >> 7538175

Amino-terminal regions of polyomavirus middle T antigen are required for interactions with protein phosphatase 2A.

G M Glenn1, W Eckhart.   

Abstract

Polyomavirus middle T antigen (MT) is the major transforming protein of the virus. It functions through interactions with a number of cellular proteins involved in cell proliferation. MT forms complexes with protein phosphatase 2A (PP2A), pp60c-src, phosphatidylinositol 3-kinase, and Shc. We introduced both deletion and point mutations into three regions of MT and examined their ability to associate with PP2A and pp60c-src. The first 25 amino acid residues of MT are required for association with PP2A and pp60c-src. Amino acids 105 to 111, comprising the sequence Cys-Arg-Met-Pro-Leu-Thr-Cys, is also required for complex formation between MT and PP2A. However, the sequence Asp-Lys-Gly-Gly (amino acids 44 to 47), also found in the B subunit of PP2A, is dispensable for complex formation between MT and PP2A. We find a strict correlation between the ability of MT to associate with PP2A and the ability of MT to associate with pp60c-src. One mutant, L5E, associates with a phosphatase other than PP2A, pp60c-src, and phosphatidylinositol 3-kinase in a manner similar to that of wild-type MT yet is reduced in its transforming ability on NIH 3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538175      PMCID: PMC189089     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  cDNA cloning with a retrovirus expression vector: generation of a pp60c-src cDNA clone.

Authors:  P L Kaplan; S Simon; C A Cartwright; W Eckhart
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

2.  Association of protein phosphatase 2A with polyoma virus medium tumor antigen.

Authors:  G Walter; R Ruediger; C Slaughter; M Mumby
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

3.  Tumor antigen(s) in cell productively infected by wild-type polyoma virus and mutant NG-18.

Authors:  B S Schaffhausen; J E Silver; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

Review 4.  Signal-dependent membrane protein trafficking in the endocytic pathway.

Authors:  I S Trowbridge; J F Collawn; C R Hopkins
Journal:  Annu Rev Cell Biol       Date:  1993

5.  Association of p60fyn with middle tumor antigen in murine polyomavirus-transformed rat cells.

Authors:  I D Horak; T Kawakami; F Gregory; K C Robbins; J B Bolen
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

Review 6.  The structure and regulation of protein phosphatases.

Authors:  P Cohen
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

7.  Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.

Authors:  G M Glenn; W Eckhart
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Complexes of polyoma virus medium T antigen and cellular proteins.

Authors:  T Grussenmeyer; K H Scheidtmann; M A Hutchinson; W Eckhart; G Walter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.

Authors:  J B Bolen; C J Thiele; M A Israel; W Yonemoto; L A Lipsich; J S Brugge
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

10.  Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation.

Authors:  S A Courtneidge
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  17 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.

Authors:  M Shanzer; I Ricardo-Lax; R Keshet; N Reuven; Y Shaul
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

3.  Effect on polyomavirus T-antigen function of mutations in a conserved leucine-rich segment of the DnaJ domain.

Authors:  H Li; K Söderbärg; H Houshmand; Z Y You; G Magnusson
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Genetic analysis of the polyomavirus DnaJ domain.

Authors:  Kerry A Whalen; Rowena de Jesus; Jennifer A Kean; Brian S Schaffhausen
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 5.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

6.  Binding specificity of protein phosphatase 2A core enzyme for regulatory B subunits and T antigens.

Authors:  R Ruediger; K Fields; G Walter
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A.

Authors:  K P Mullane; M Ratnofsky; X Culleré; B Schaffhausen
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

8.  Tiny T antigen: an autonomous polyomavirus T antigen amino-terminal domain.

Authors:  M I Riley; W Yoo; N Y Mda; W R Folk
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

9.  pp60c-src binding to polyomavirus middle T-antigen (MT) requires residues 185 to 210 of the MT sequence.

Authors:  C E Brewster; H R Glover; S M Dilworth
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

10.  Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cells.

Authors:  E Kremmer; K Ohst; J Kiefer; N Brewis; G Walter
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.